OMNI LUX™ Patented Process Laundry Test Results
Pathogenic Killing Efficacy Report
Date: 9/29/2020
Microbiologist: Rick Van der Hoof, PhD CLS
Engineer: Ravi Verma, PhD
Test Facility: Spectral Platforms 1851 Huntington Drive, Duarte CA 91010
With the OMNI LUX™ System on, it is effective against MRSA, E. coli, C. difficile, Human Coronavirus OC43, and SARS-CoV-2 (COVID-19). This conclusion is supported by the reduction in documented MRSA and E. coli colony counts, the C. difficile colony counts, and in the reduction of OC43 and in observed SARS-CoV-2 counts. The study operators consider the observed reduction in pathogen concentration to be significant. Comparing outlet to inlet (with and without UV), UV action results in up to a 5-log, 99.999% reduction in pathogens.
SARS-CoV-2
(the virus that causes COVID-19)
Calibration vials for the cytopathic effect CPE observed with Vero E6 cells for SARS-CoV-2 (COVID-19).
C. diff
Observing cytopathic effect (CPE) with tissue culture samples and C. difficile.
MRSA
MRSA test experiments with 100 uL samples plated after a 100X dilution. From left to right: t=0 min, t=15 min, t=30 min, t=45 min. There is a significant reduction in the observed number of MRSA colonies from left to right.